Harunobu Mitsunuma

Title: Harunobu Mitsunuma: Innovator in Neuropsychiatric Medicaments

Introduction

Harunobu Mitsunuma is a distinguished inventor based in Tokyo, Japan, with a remarkable contribution to the field of neuropsychiatric medicine. With a total of three patents to his name, his work is centered around developing innovative medicaments targeting serotonin 5-HT receptor activity.

Latest Patents

Mitsunuma's latest patents reflect his dedication to advancing treatments for neuropsychiatric diseases. One of his notable inventions, titled "Substituted Pyrazoles Showing Serotonin 5-HT Receptor Activity," relates to a medicament comprising a compound of Formula (1) or a pharmaceutically acceptable salt thereof, serving as an active ingredient. Another significant patent is for "Substituted Lactams Showing Serotonin 5-HT Receptor Activity," which similarly focuses on compounds intended for treating neuropsychiatric conditions.

Career Highlights

Throughout his career, Harunobu Mitsunuma has made substantial contributions while working with prominent companies such as Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His affiliations with these reputable organizations have bolstered his research capabilities and focus on developing therapeutic solutions in psychiatry.

Collaborations

Mitsunuma has collaborated with notable coworkers, including Hidefumi Yoshinaga and Yohei Ikuma. These partnerships have facilitated the exchange of ideas and innovations, further enhancing the impact of his work in the medicinal field.

Conclusion

Harunobu Mitsunuma stands out as a pioneering inventor in the domain of neuropsychiatric medicines. His patents not only illustrate his innovation in creating effective treatments but also highlight the collaborative efforts that drive progress in medical research. As he continues his work, the medical community anticipates further advancements that will emerge from his research and inventions.